Arrangement of Collecting Venules for the Endoscopic Diagnosis of Helicobacter Pylori

NCT ID: NCT05046990

Last Updated: 2023-03-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To perform a prospective, observational, international, multicentre, in vivo study to assess the performance of regular arrangement of collecting venules (RAC) for the exclusion of Helicobacter pylori (Hp) infection using white light high definition (HD) endoscopy without any kind of zoom or magnification.

Gold standard will be mucosal biopsies (Sydney protocol) or urease test. Immunohistochemistry (IHC) should be performed in case of a negative histologic study for Hp in patients taking proton pump inhibitors (PPIs).

Participants will perform a training test with 20 pictures of the distal part of the lesser curvature before starting the inclusion of cases.

Secondary objectives are:

* To assess whether age, sex and PPIs, have an influence on the results of RAC.
* To assess the correlation of atrophic gastritis and intestinal metaplasia (confirmed in histopathological samples) and RAC.
* To assess reproducibility of RAC on real time examinations with different operators and in different countries with different Hp infection prevalence.

Primary and secondary variables

The primary study variable is:

\- Endoscopic detection of RAC.

Secondary variables will be considered:

* Sex
* Age
* PPI intake in the last two weeks
* Centre
* Country
* Hp prevalence
* Endoscopist
* Type of endoscope
* Significant findings (need of histological confirmation)

* Atrophic gastritis
* Intestinal metaplasia
* Erosive gastritis
* Benign gastric ulcer
* Gastric adenoma
* Gastric cancer

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multicentre, international study without a control group.

Training phase Before starting the inclusion of patients, 20 HD images previously collected by the principal investigator will be sent to each of the study investigators. Pictures will clearly show the RAC pattern present or absent at the level of the distal gastric lesser curvature. In case of doubtful RAC, the pattern shall be considered negative. Investigators will be able to discuss their questions and doubts after the training phase (videoconference).

Endoscopic examination Upper endoscopy will be performed with HD endoscopes and a high-definition screen. Two endoscopists will participate in each hospital. The examination will be performed according to the protocol of each centre. Visualisation of the entire oesophageal, gastric and duodenal surface will be performed as in routine clinical practice. The presence of RAC will be assessed during the gastric exploration with sufficient insufflation and its detection will be considered as the presence of a regular starfish-shaped erythematous punctation in the lower part of the lesser curvature of the gastric body, close to the incisura angularis.

In case of the presence of residues in the gastric cavity that prevent the correct visualisation of the area, water washings shall be performed for the correct characterisation of the mucosa. At least one photo of the described gastric region shall be taken with the image processor system to maintain its high-definition quality. All the data (name, date of birth, clinical record number, date of exploration…) will be removed from the picture to ensure the anonymisation. Subsequently, the photographs will be downloaded and saved in a folder on a network drive of each hospital.

After characterisation of the gastric mucosa, the Hp infection status will be assessed by taking biopsies with a standard forceps for anatomopathological study according to Sydney's protocol (2 in the antrum, 1 in the incisura and 2 in the body). Ideally, biopsies for a urease test will also be obtained.

Histopathological examination Samples shall be fixed in formalin and analysed by the Anatomical Pathology service for histological examination by haematoxylin and eosin (H\&E) and special staining for Hp (e.g. modified Giemsa). In patients taking PPI, if Hp is negative in the H\&E histological study, the study will be completed by immunohistochemical (IHC) staining.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Helicobacter Pylori Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RAC evaluation

Patients older than 18 years without previous history of Hp infection or eradication undergoing a gastroscopy

Regular Arrangement of Collecting Venules

Intervention Type DIAGNOSTIC_TEST

This is a prospective, multicentre, international study without a control group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Regular Arrangement of Collecting Venules

This is a prospective, multicentre, international study without a control group.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 18 years without previous history of Hp infection or eradication undergoing a gastroscopy

Exclusion Criteria

* Patients taking oral anticoagulants (acenocoumarol and new anticoagulants as dabigatran, rivaroxaban, apixaban and edoxaban), NSAIDs or with intake of antibiotics in the last 4 weeks, but aspirin at a dose of 100 mg per day will be included
* Diseases that affect the gastric mucosa and preclude the evaluation of the collecting venules pattern (portal hypertension, gastric lymphoma)
* History of previous gastric cancer or patients in surveillance for preneoplastic lesions (atrophic gastritis/IM),
* Previous gastric surgery,
* Active bleeding or presence of blood or food that would impede a complete mucosal evaluation.
* Negative to participate in the study or inability to provide signed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Clinic of Barcelona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gloria Fernandez-Esparrach, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Clinic of Barcelona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires Saint Luc

Brussels, , Belgium

Site Status RECRUITING

München University Hospital

Munich, Bavaria, Germany

Site Status RECRUITING

Hospital de Mérida

Mérida, Badajoz, Spain

Site Status COMPLETED

Hospital de Viladecans

Viladecans, Barcelona, Spain

Site Status ACTIVE_NOT_RECRUITING

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium Germany Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gloria Fernandez-Esparrach, PhD

Role: CONTACT

+34932275400

Rodrigo Garces-Duran, MD

Role: CONTACT

+34932275400

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rodrigo GARCES-DURAN, PHD

Role: primary

+32456126169

Riccardo Vasapolli, MD

Role: primary

Gloria Fernandez-Esparrach, PHD

Role: primary

+34932275400

References

Explore related publications, articles, or registry entries linked to this study.

Garces-Duran R, Galdin-Ferreyra M, Delgado-Guillena PG, Cuatrecasas M, Cordova H, Garcia-Rodriguez A, Rodrigo-Calvo MT, Jimeno-Ramiro M, Araujo IK, Gines A, Llach J, Fernandez-Esparrach G. Diagnosis of Helicobacter pylori Infection by the Arrangement of Collecting Venules Using White Light Endoscopy: Evaluation of Interobserver Agreement. Dig Dis. 2022;40(3):376-384. doi: 10.1159/000518100. Epub 2021 Jun 30.

Reference Type BACKGROUND
PMID: 34348294 (View on PubMed)

Garces-Duran R, Garcia-Rodriguez A, Cordova H, Cuatrecasas M, Gines A, Gonzalez-Suarez B, Araujo I, Llach J, Fernandez-Esparrach G. Association between a regular arrangement of collecting venules and absence of Helicobacter pylori infection in a European population. Gastrointest Endosc. 2019 Sep;90(3):461-466. doi: 10.1016/j.gie.2019.05.027. Epub 2019 May 17.

Reference Type BACKGROUND
PMID: 31108089 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HCB-RAC-MOTIVATION

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HEP-FYN 12-Years Follow-up
NCT02001727 UNKNOWN NA